CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancerTianyi Cheng, Chen Huang, Yingyi Wu et al.|Frontiers in Immunology|2022Cited by 66